Dasenbrook E.C. Checkley W. Merlo C.A. Konstan M.W. Lechtzin N. Boyle M.P.

Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis.

JAMA. 2010; 303 (Jun 16): 2386-2392Ren C.L. Morgan W.J. Konstan M.W. et al.

Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.

Pediatr Pulmonol. 2007; 42 (Jun): 513-518Sanders D.B. Bittner R.C. Rosenfeld M. Hoffman L.R. Redding G.J. Goss C.H.

Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation.

Am J Respir Crit Care Med. 2010; 182 (Sep 1): 627-632https://doi.org/10.1164/rccm.200909-1421OCHeltshe S.L. Saiman L. Popowitch E.B. et al.

Outcomes and treatment of chronic methicillin-resistant Staphylococcus aureus differs by Staphylococcal cassette chromosome mec (SCCmec) type in children with cystic fibrosis.

J Pediatric Infect Dis Soc. 2015; 4 (Sep): 225-231https://doi.org/10.1093/jpids/piu048Esther Jr., C.R. Muhlebach M.S. Ehre C. et al.

Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis.

Sci Transl Med. 2019; 11 (Apr 3)https://doi.org/10.1126/scitranslmed.aav3488Cowley E.S. Kopf S.H. LaRiviere A. Ziebis W. Newman D.K.

Pediatric cystic fibrosis sputum can be chemically dynamic, anoxic, and extremely reduced due to hydrogen sulfide formation.

MBio. 2015; 6 (Jul 28): e00767https://doi.org/10.1128/mBio.00767-15Sibley C.D. Parkins M.D. Rabin H.R. Duan K. Norgaard J.C. Surette M.G.

A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

PNAS. 2008; 105 (Sep 30): 15070-15075https://doi.org/10.1073/pnas.0804326105Muhlebach M.S. Hatch J.E. Einarsson G.G. et al.

Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study.

Eur Respir J. 2018; 52 (Jul)https://doi.org/10.1183/13993003.00242-2018

Biology and management of methicillin resistant Staphylococcus aureus in cystic fibrosis.

Pediatr Pulmonol. 2018; 53 (Nov): S64-s74https://doi.org/10.1002/ppul.24139Savage V.J. Chopra I. O'Neill A.J.

Population diversification in Staphylococcus aureus biofilms may promote dissemination and persistence.

PLoS ONE. 2013; 8: e62513https://doi.org/10.1371/journal.pone.0062513Kahl B. Herrmann M. Everding A.S. et al.

Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis.

J Infect Dis. 1998; 177 (Apr): 1023-1029Wolter D.J. Onchiri F.M. Emerson J. et al.

Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study.

Lancet Respir Med. 2019; 7 (Dec): 1027-1038https://doi.org/10.1016/S2213-2600(19)30365-0Hirschhausen N. Block D. Bianconi I. et al.

Extended Staphylococcus aureus persistence in cystic fibrosis is associated with bacterial adaptation.

Int J Med Microbiol. 2013; 303 (Dec): 685-692https://doi.org/10.1016/j.ijmm.2013.09.012Hankinson J.L. Odencrantz J.R. Fedan K.B.

Spirometric reference values from a sample of the general U.S. population.

Am J Respir Crit Care Med. 1999; 159: 179-187Larsen A.R. Stegger M. Sorum M.

Spa typing directly from a mecA, spa and pvl multiplex PCR assay-a cost-effective improvement for methicillin-resistant Staphylococcus aureus surveillance.

Clin Microbiol Infect. 2008; 14 (Jun): 611-614https://doi.org/10.1111/j.1469-0691.2008.01995.xLina G. Piemont Y. Godail-Gamot F. et al.

Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Clin Infect Dis. 1999; 29 (Nov): 1128-1132https://doi.org/10.1086/313461Shopsin B. Gomez M. Montgomery S.O. et al.

Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains.

J Clin Microbiol. 1999; 37 (Nov): 3556-3563Mellmann A. Weniger T. Berssenbrugge C. et al.

Based Upon Repeat Pattern (BURP): an algorithm to characterize the long-term evolution of Staphylococcus aureus populations based on spa polymorphisms.

BMC Microbiol. 2007; 7 (Oct 29): 98https://doi.org/10.1186/1471-2180-7-98Stepanovic S. Vukovic D. Hola V. et al.

Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by Staphylococci.

APMIS. 2007; 115 (Aug): 891-899https://doi.org/10.1111/j.1600-0463.2007.apm_630.xChen X. Thomsen T.R. Winkler H. Xu Y.

Influence of biofilm growth age, media, antibiotic concentration and exposure time on Staphylococcus aureus and Pseudomonas aeruginosa biofilm removal in vitro.

BMC Microbiol. 2020; 20 (Aug 24): 264https://doi.org/10.1186/s12866-020-01947-9Jaskiewicz M. Neubauer D. Kamysz W.

Comparative study on antistaphylococcal activity of lipopeptides in various culture media.

Antibiotics. 2017; 6 (Aug 2)https://doi.org/10.3390/antibiotics6030015Gomes-Fernandes M. Laabei M. Pagan N. et al.

Accessory gene regulator (Agr) functionality in Staphylococcus aureus derived from lower respiratory tract infections.

PLoS ONE. 2017; 12e0175552https://doi.org/10.1371/journal.pone.0175552Lee T.W. Brownlee K.G. Conway S.P. Denton M. Littlewood J.M.

Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.

J Cyst Fibros. 2003; 2: 29-34Tenover F.C. Goering R.V.

Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology.

J Antimicrob Chemother. 2009; 64 (Sep): 441-446https://doi.org/10.1093/jac/dkp241Champion E.A. Miller M.B. Popowitch E.B. et al.

Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.

Pediatr Pulmonol. 2013; 49 (Jun 14): 230-237https://doi.org/10.1002/ppul.22815

Effect of anaerobiosis on antimicrobial susceptibility of staphylococci.

Antimicrob Agents Chemother. 1977; 11 (Jun): 1077-1078https://doi.org/10.1128/aac.11.6.1077Waters V.J. Kidd T.J. Canton R. et al.

Reconciling antimicrobial susceptibility testing and clinical response in antimicrobial treatment of chronic cystic fibrosis lung infections.

Clin Infect Dis. 2019; 69 (Oct 30): 1812-1816https://doi.org/10.1093/cid/ciz364Lo D.K. Muhlebach M.S. Smyth A.R.

Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.

Cochrane Database Syst Rev. 2018; 7 (Jul 21)CD009650https://doi.org/10.1002/14651858.CD009650.pub4Gabryszewski S.J. Wong Fok Lung T. Annavajhala M.K. et al.

Metabolic adaptation in methicillin-resistant Staphylococcus aureus pneumonia.

Am J Respir Cell Mol Biol. 2019; 61 (Aug): 185-197https://doi.org/10.1165/rcmb.2018-0389OCTan X. Coureuil M. Ramond E. et al.

Chronic Staphylococcus aureus lung infection correlates with proteogenomic and metabolic adaptations leading to an increased intracellular persistence.

Clin Infect Dis. 2019; 69 (Nov 13): 1937-1945https://doi.org/10.1093/cid/ciz106Pragman A.A. Yarwood J.M. Tripp T.J. Schlievert P.M.

Characterization of virulence factor regulation by SrrAB, a two-component system in Staphylococcus aureus.

J Bacteriol. 2004; 186 (Apr): 2430-2438https://doi.org/10.1128/jb.186.8.2430-2438.2004Fuchs S. Pane-Farre J. Kohler C. Hecker M. Engelmann S.

Anaerobic gene expression in Staphylococcus aureus.

J Bacteriol. 2007; 189 (Jun): 4275-4289https://doi.org/10.1128/JB.00081-07

Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. Review.

J Clin Microbiol. 2003; 41: 4009-4015Goerke C. Gressinger M. Endler K. et al.

High phenotypic diversity in infecting but not in colonizing Staphylococcus aureus populations.

Environ Microbiol. 2007; 9 (Dec): 3134-3142https://doi.org/10.1111/j.1462-2920.2007.01423.xAl-Zubeidi D. Hogan P.G. Boyle M. Burnham C.A. Fritz S.A.

Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated in serial cultures from the respiratory tract of children with cystic fibrosis.

Pediatr Infect Dis J. 2014; 33 (Jun): 549-553https://doi.org/10.1097/inf.0000000000000204Kahl B.C. Duebbers A. Lubritz G. et al.

Characteristics of Staphylococcus aureus, isolated from airways of cystic fibrosis patients, and their small colony variants.

J Clin Microbiol. 2003; 41 (Sep Feb 18): 4424-4427Azarian T. Ridgway J.P. Yin Z. David MZ.

Long-term intrahost evolution of methicillin resistant Staphylococcus aureus among cystic fibrosis patients with respiratory carriage.

Front Genet. 2019; 10: 546https://doi.org/10.3389/fgene.2019.00546Goodrich J.S. Sutton-Shields T.N. Kerr A. Wedd J.P. Miller M.B. Gilligan P.H.

Prevalence of community-associated methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis.

J Clin Microbiol. 2009; 47 (Apr): 1231-1233